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ABSTRACT
Objective: Hispanics in the USA are affected by the
diabetes epidemic disproportionately, and they
consistently have lower access to care, poorer control
of the disease and higher risk of complications. This
study evaluates whether a community health worker
(CHW) intervention may improve clinically relevant
markers of diabetes care in adult underserved
Hispanics.
Methods and analysis: The Northern Manhattan
Diabetes Community Outreach Project (NOCHOP) is
a two-armed randomised controlled trial to be
performed as a community-based participatory
research study performed in a Primary Care Setting in
Northern Manhattan (New York City). 360 Hispanic
adults with poorly controlled type 2 diabetes mellitus
(haemoglobin A1c >8%), aged 35e70 years, will be
randomised at a 1:1 ratio, within Primary Care Provider
clusters. The two study arms are (1) a 12-month CHW
intervention and (2) enhanced usual care (educational
materials mailed at 4-month intervals, preceded by
phone calls). The end points, assessed after
12 months, are primary ¼ haemoglobin A1c and
secondary ¼ blood pressure and low-density
lipoprotein-cholesterol levels. In addition, the study
will describe the CHW intervention in terms of
components and intensity and will assess its effects on
(1) medication adherence, (2) medication
intensiﬁcation, (3) diet and (4) physical activity.
Ethics and dissemination: All participants will
provide informed consent; the study protocol has been
approved by the Institutional Review Board of
Columbia University Medical Center. CHW
interventions hold great promise in improving the well-
being of minority populations who suffer from diabetes
mellitus. The NOCHOP study will provide valuable
information about the efﬁcacy of those interventions
vis-a `-vis clinically relevant end points and will inform
policy makers through a detailed characterisation of
the programme and its effects.
Clinical trial registration number: NCT00787475
at clinicaltrials.gov.
INTRODUCTION
The current diabetes epidemic affects US
Hispanics disproportionately, both in preva-
lence and frequency of complications as
compared with Caucasians.
1 Hispanics suffer
from less access to care and poorer control of
their diabetes.
23On the other hand, there is
a great paucity of culturally appropriate
models of care that maximise access and
enhance healthcare delivery in Hispanics.
45
The lack of such models perpetuates the role
of language and culture as ‘barriers to care’.
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ARTICLE SUMMARY
Article focus
- Randomised controlled trial.
- CHW intervention.
- Diabetes care.
Key messages
- This community-based participatory research
study is a collaboration between a community
organisation and a university in Northern
Manhattan, New York City.
- The goal is to assess whether the CHW worker
intervention may improve diabetes care in under-
served adult Hispanics from the community.
- The primary outcome of interest is haemoglobin
A1c, a marker of diabetes control; secondary
outcomes are blood pressure and low-density
lipoprotein cholesterol levels.
Strengths and limitations of this study
- This study will examine effects of the CHW
intervention after 12 months, a longer time
period than in previous studies.
- The CHW intervention protocol was developed in
a culturally appropriate manner to address the
needs of Hispanics residing in our community.
- If proven efﬁcacious, it will warrant examination
in other cultural socioeconomic milieus.
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Open Access ProtocolThus, there is great interest in patient-cantered inter-
ventions that, instead, embrace the culture and language
of our patients. This paradigm shift has the potential to
transform those perceived ‘barriers’ into integral
components of the intervention, empowering patients
and their families in dealing with diabetes mellitus and
helping them navigate the complexities of our medical
system.
Community health workers (CHWs, known as Promo-
toras or Promotores de Salud in Spanish) have been shown
to be efﬁcacious in improving healthcare delivery
around the world, including Latin America and the
USA.
6 However, a better characterisation of the efﬁcacy
of CHW interventions is needed, particularly in regards
to widely accepted clinical end points, such as serum
haemoglobin A1c (A1c, a measure of blood glucose
levels over the previous weeks), blood pressure and
cholesterol levels. Several randomised controlled trials
(RCTs) have been performed to assess the potential
beneﬁts of CHW interventions in improving the care of
minority populations with diabetes. However, those trials
recruited relatively small numbers of participants and
were carried out for rather short periods of time.
7e13
Indeed, as recently reviewed, data from some of those
studies suggest that short-term efﬁcacy achieved in
lowering A1c is later lost at 12 months.
14 Systematic
reviews and meta-analyses have also highlighted the need
for larger and longer term RCTs in Hispanic and
other underserved communities.
14e17 In addition to
clinically relevant end points (such as A1c lowering),
there is a clear need for interventions that are well
described both in nature and intensity and that target
a well-deﬁned population.
17
We describe here the protocol of a study designed to
address those gaps in knowledge, the Northern
Manhattan Diabetes Community Outreach Project
(NOCHOP). The NOCHOP is a RCT to evaluate the
efﬁcacy of a 12-month CHW intervention to improve the
care of Hispanics with poorly controlled type 2 diabetes
mellitus. It is a two-arm study with an active control
group, designed such that the control group receives
enhanced standard care. It is a community-based
participatory research enterprise designed and
conducted by two partner institutions from Northern
Manhattan: Alianza Dominicana, Inc., and Columbia
University.
METHODS AND ANALYSIS
Study outcomes
The primary study outcome is glycaemic control,
measured by A1c. The secondary outcomes are systolic
and diastolic blood pressure and low-density lipoprotein
(LDL) cholesterol levels. We also are collecting data,
which will allow examination of the putative mechanisms
that may account for the hypothesised effects of the
intervention in this population. Data are being collected
during the intake and 1-year follow-up examination on
the following mechanistic end points: (1) medication
adherence, (2) medication intensiﬁcation, (3) diet and
(4) physical activity.
Study participants
NOCHOP is an RCT of 360 Hispanic participants with
poorly controlled type 2 diabetes, aged 35e70 years and
who are currently receiving care at one of our primary
care practice sites in Northern Manhattan.
18 Participants
are classiﬁed as having poorly controlled diabetes if their
last A1c measurement (performed in the preceding
12 months) was $8.0. Exclusion criteria are (1) type 1
diabetes and/or diabetes with onset before age of 25; (2)
subjects who do not self-identify as Hispanic; (3) any life-
threatening or extreme medical comorbidity, such as an
active cancer or end-stage cardiopulmonary disease; (4)
having a diabetes diagnosis for <1 year; (5) planning to
move out of the neighbourhood during the next year;
(6) enrolment in any other study and (7) arm circum-
ference of >47 cm (due to inability to accurately
measure blood pressure using an oscillometric device).
All participants provide informed consent prior to
enrolment; the study protocol has been approved by the
Institutional Review Board (IRB) of Columbia University
Medical Center. Consent is obtained by trained study
personnel, following IRB-approved procedures. Recruit-
ment is performed within the Primary Care Clinics at
Columbia University Medical Center, and it is centred
around Primary Care Physicians (PCP), who approve all
contacts with potential participants. This approach has
proven successful for our group when recruiting, from
the same population, for a recent RCT of innovative
diabetes care management.
19 Moreover, the collabora-
tion with Alianza Dominicana, the largest and best-
known community organisation in our neighbourhoods,
probably enhances recruitment.
Participant attrition is usually a concern in trials
enrolling underserved populations, as it may compro-
mise the statistical power of the study. Thus, steps are
taken in both arms to maximise retention. In the inter-
vention arm, CHWs regularly stress the importance to all
participants of undergoing their 12-month evaluation
visit, and they use reminders when approaching the end
of the intervention. In the control arm, the study coor-
dinator takes the opportunity provided by the scheduled
phone calls (see below) to address this issue. Based on
the intention-to-treat principle, all efforts will be made to
bring participants back for the 12-month evaluation visit.
For those participants who are unable or unwilling to
undergo that evaluation, sensitivity analyses will be
performeddplease see the Statistical analysis methods
section, for a description of our analytic approach to
missing data. Of note, as described in the supplementary
data ﬁle, our sample size was determined using
a conservative approach to attrition when modelling the
statistical power estimates.
Randomisation
After providing informed consent, participants are
remotely and blindly randomised (1:1) to either
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Community health workers for diabetes careintervention (CHW intervention for 12 months) or to
enhanced usual care (EUC) by the Research Depart-
ment at the Hebrew Home at Riverdale, NY. Random-
isation is clustered within PCP practice; the algorithm
accounts for rolling enrolment within PCPs. Balance
between the two study arms is checked periodically.
Procedures
All participants undergo two examination visits: one at
baseline and another one at the end of the participation
a year later. Personnel performing evaluation visits are
blinded to randomisation status. Subjects are instructed
to come to examinations fasting, and having held their
diabetes medications, but taking their blood pressure
medications. Questionnaire data are obtained during
examination visits using a computer-assisted telephone
interviewing system.
20
Measures
Height and weight are measured without shoes and
wearing lightweight clothes and using a stadiometer and
a validated digital scale. All measurements are recorded to
the nearest 0.1 cm/0.1 kg. Specimens are analysed in
blinded fashion by the Columbia University CRC Core
Laboratory. A1c is measured using a latex agglutination
assay (Hitachi 912 Polymedco Inc., Cortlandt Manor, New
York, USA). Total cholesterol, triglyceride and high-
density lipoprotein cholesterol is measured using enzy-
matic colorimetric methods (Vitros, Johnson & Johnson,
New Brunswick, New Jersey, USA). LDL cholesterol is
calculated using the Friedewald equation.
21 For subjects
with triglyceride level $300 mg/dl, LDL cholesterol is
measured directly using a homogeneous assay (Poly-
medco, Cortlandt Manor, New York, USA). Resting blood
pressure is measured using a BpTRU automated oscillo-
metric device (VSM Tech Ltd, Coquitlam, BC, Canada).
Three measurements are obtained following 5 min of rest.
The average of the second and third measurements is
recorded as the resting blood pressure. Other constructs
measured include medication adherence,
22 dosage and
intensity,
23 physical activity,
24 diet
25 and depression.
26
CHW intervention
Basic features
The CHW intervention is based on (1) existing
consensus of successful diabetes interventions in vulner-
able populations and (2) its promise as a sustainable
generalisable intervention. Two full time CHWs based at
Alianza Dominicana, Inc., are delivering a multicompo-
nent intervention that includes home visits, group visits
and telephone follow-up, the focus of the home visits is
on assessment of existing barriers to healthcare (diabetes
and non-diabetes), empowering the patient to overcome
these barriers and then developing achievable goals for
the upcoming year. The group visits focuses on nutrition
and exercise activities. The phone intervention serves as
a follow-up mechanism for adherence to the individu-
alised plan and reinforcement. The intervention is
summarised in ﬁgure 1 of the supplementary data. CHW
intervention is ﬂexible and tailored to each participant’s
needs, but the goal will be to perform at least four home
visits, 10 group sessions and 10 follow-up phone calls per
subject over a 12-month period.
CHW medical service/patient navigator activities
Self-management is key to the CCM, and fundamental to
this is empowering patients to make effective use of the
healthcare system.
27 28 This requires a positive and
productive relation with the PCP, wherein the patient is
comfortable in asking questions and speaking honestly
about concerns regarding medications.
29 30 Through
individual and group activities, the CHWs help the
participants develop communication and self-advocacy
skills to be able to take a more active role in their visits.
They teach participants how to maximise their time with
the provider, how to advocate for themselves and what
questions they should ask. Additional patient navigator
activities by CHWs during the home visit may include
reminding patients of their next appointments and, if
needed, setting up home medication reminder systems
for patients such as refrigerator charts noting when it is
time to get reﬁlls.
Referrals
The CHWS also assist the participants in accomplishing
their goals by connecting them to needed services. The
CHWS make referrals to community-based resources,
both for social and healthcare services. One example
would be if the participant is facing eviction or experi-
encing problems such as domestic violence. Alianza has
speciﬁc programmes for housing and domestic violence
and the CHWS facilitate referrals; if not available
through Alianza, they are referred to other community
partners where such services would be available.
Informatics support for CHWs
The CHWs have remote real-time access to participant
data, in a HIPAA-compliant manner,
31 through secure
access to a dedicated database.
EUC arm of the study
Patients randomised to the control group receive usual
care from their PCP. This includes routine monitoring
and care from the PCP and the possibility of referral to
several existing diabetes management resources, among
them the multidisciplinary comprehensive Naomi Berrie
Diabetes Center at Columbia University Medical Center.
The N. Berrie Center resources comprise a multidisci-
plinary team of endocrinologists, certiﬁed diabetes
educators and nurse case managers who provide inten-
sive diabetes case management requiring very involved
patient participation. Providers can also refer patients to
the Visiting Nurse Service of New York. The Visiting
Nurse Service programme includes nurses, nutritionists
and diabetes educators who can deliver home-based
diabetes care and education to patients. This service is
ideal for those older patients who are home-bound. In
addition, our primary care clinic has a certiﬁed diabetes
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diabetes education, group diabetes classes and, if
requested, can assist providers with case management. In
NOCHOP, PCPs remain free to use any of these existing
resources for their patients, at their discretion. The usual
care received will be enhanced by providing patients
with three sets of Spanish language educational mate-
rials published by the National Institutes of Health.
These materials include information on communication
between physician and patient, diabetes management,
mental health and a diabetes cookbook. During the 12-
month period, a project coordinator calls EUC patients
four times. The goals of the phone calls are to (1) ensure
that the participants have received the mailed brochures
and that they ﬁnd those brochures appropriate for their
own literacy and (2) maximise retention in the study,
aiming to reduce attrition in this group.
STATISTICAL ANALYSIS METHODS
Sample size and power
The sample size was chosen to ensure sufﬁcient power to
detect clinically meaningful effects associated with
a change in A1c as a continuous outcome. The calcula-
tions performed indicate that the proposed sample size
of 360 (180 per arm) will provide sufﬁcient power for the
main study hypotheses, under a variety of assumptions.
The power calculations, including a detailed description
of assumptions and scenarios, are described in detail in
the supplementary ﬁle.
Unit of analysis and clustering
The patient will constitute the unit of analysis for the
study. Patients will be randomised within PCP; therefore,
sample sizes must be larger to account for unreliability of
measures and for design features.
32e34 Both correlation
among repeated measures over time on the same subject
and correlation due to clustering of patients within
providers (characteristics of the providers or practice
which may inﬂuence outcomes among their patients)
will be taken into account. This dependency among
members of the cluster will inﬂate the variance of the
effect of the intervention.
35
Adjustment for multiple comparisons
Adjustment for multiple comparisons is an area of
controversy.
36e40 Following recent guidelines for clinical
trials,
41 we propose to treat primary and secondary
outcomes as separate clusters, setting a 0.05 level of
signiﬁcance to the primary outcome within each cluster.
A Bonferroni or BenjaminieHochberg correction would
be applied to secondary treatment outcomes. Thus,
a 0.05 level will be assigned to the A1c outcome and
a 0.01 level to the three secondary outcomes (LDL,
diastolic blood pressure and systolic blood pressure).
Analyses
A parallel group design with equivalent baseline values
as a result of randomisation is proposed. Calculations are
provided for the primary outcome treated as continuous
and as binary. The main analyses will be performed using
continuous data. Analyses of A1c treated as binary
assumes intent-to-treat and that all dropout and missing
data are considered as failures. Thus, the proportion of
successes is based on the entire sample randomised.
However, in the context of cost limitations, large
samples are required to examine small effects when
continuous data are treated as binary because of the
severe loss of power associated with dichotomising
a normally distributed dependent variable such as A1c.
Dichotomisation of skewed variables leads to even
greater loss of power.
42 Additionally, there are theoret-
ical considerations that include the fact that in health
disparities research, stringent goals, for example,
complete glycaemic control, may not be realised and one
may consider smaller average reductions in outcomes as
clinically meaningful.
The general approach to the analyses is guided by our
own experience in the analyses of such data
43 44 and by
recent reviews of best methods for analyses of longitu-
dinal data from clinical trials.
45 Because the design is to
randomise individuals to groups within PCP strata, some
baseline imbalance in the outcome might occur; in this
case, the basic analytic approach will be analysis of
covariance (ANCOVA) model that adjusts for baseline
values of the outcome, as well as for the design feature of
clustering. In order to determine the best approach, two
basic models could be examined. One is a basic t test or
ANCOVA approach, with inclusion of a random effect
for PCP to model the clustered data. The second is
a repeated measures approach that examines time as
continuous. The latter allows inclusion of more subjects,
however, with only two waves of data (and if 90% of the
subjects are interviewed within 62 months of the 12-
month mark), it is not clear that there will be sufﬁcient
beneﬁts associated with the approach. The post-treat-
ment values of continuous outcomes will be modelled as
functions of baseline values, treatment and the interac-
tion of baseline and treatment. A general longitudinal
mixed effects model, using SAS PROC MIXED, will be
used to allow for the correlation between subjects within
a PCP. Additionally, the group heterogeneity in cluster
and residual variances may require modelling to satisfy
model assumptions and improve model ﬁt. (There may
be violations of the more rigid assumptions involved in
ANCOVA, such as homoscedasticity, so that modelling
the group heterogeneity in cluster and residual variances
will be necessary.) Based on prior analytic experience
with the outcome variables, the need to transform them
is not anticipated. Although the primary analysis is to
examine A1c as a continuous measure, it is also
proposed to treat A1c as a binary outcome deﬁning
those with poor glycaemic control as A1c $9.0. In this
case, dichotomous outcome measures will be analysed
using generalised estimating equations to account for
potentially correlated outcomes of subjects with the
same PCP (PROC GLIMMIX in SAS). Prior to analyses,
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examined; however, no p values will be provided, and
covariates (other than baseline values) are not proposed
for inclusion in the main analyses of treatment effects.
Examination of baseline differences on key variables
between subjects remaining and those lost to follow-up
will also be conducted. The ﬁrst set of analyses will not
adjust for dropout. Only cases with complete data will be
included; however, as stated, these analyses will include
those who did not complete the CHW intervention but
who returned to provide the follow-up interview, under
an intent-to-treat design. The intent-to-treat analyses of
the total group could be repeated using baseline values
carried forward to account for cases lost to follow-up
(using SAS PROC MIXED). However, baseline values
carried forward is not optimal, depending on the type of
variable studied.
46 For example, blood pressure may
increase over time due to ageing. Thus, other methods
of examining missing data, for example, propensity
scores, EM algorithm and multiple imputation sensitivity
analyses, will be considered.
ETHICS AND DISSEMINATION
Data and Safety Monitoring Board
The Data and safety monitoring board (DSMB, also
known as a Data Monitoring Committee) is an inde-
pendent four-member multidisciplinary group consisting
of biostatisticians and clinicians that collectively have
experience in the management of patients and in the
conduct and monitoring of randomised clinical trials. It
is responsible for safeguarding the interests of trial
participants, assessing the safety and efﬁcacy of the
interventions during the trial and for monitoring the
overall conduct of the clinical trial. A detailed descrip-
tion of the NOCHOP DSMB and its duties can be found
in the DSMB Charter, in the supplementary data ﬁle.
Protection of participant privacy
The NOCHOP study adheres to the privacy rules insti-
tuted by the Health Insurance Portability and Account-
ability Act of 1996 (HIPAA). All examination data are
electronically transmitted using encryption software at
the end of the visit, and all data are stored in ﬁrewall-
protected servers. Data analysis will be performed in de-
identiﬁed data sets (ie, sets that contain no participant
identiﬁers, as deﬁned by HIPAA). Moreover, only de-
identiﬁed data sets will be shared using IRB-authorised
procedures or (upon request) with the National Insti-
tutes of Health.
Relevance and dissemination
Our project seeks to examine the efﬁcacy of a CHW
intervention to improve the care of adult Hispanics with
type 2 diabetes in Northern Manhattan. CHW interven-
tions are rooted in over 30 years of culturally tailored
public health service delivery in Hispanic communities.
The acceptability of this approach to enhance healthcare
delivery has been shown in Hispanic populations in
numerous studies. An additional strength of the
community-based design is that it will not further tax the
already limited resources of health providers caring for
low-income minority populations, such as inner-city
clinics. In addition, this project will help characterise the
speciﬁc components of a CHW intervention that lead to
an improvement in clinically and socially relevant
outcomes in this high-risk population. In doing so,
NOCHOP is expected to make a substantial contribution
to the ongoing national debate about the sustainability
and optimal design of CHW programmes.
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